Thasso
the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
Log in
Main Navigation
‹ Return to Theragenomics: Ivacaftor (Kalydeco) in the CFTR mutation-based treatment of cystic fibrosis (CF)
Cystic Fibrosis (CF). Possibly dead at 18.
You must be logged in to post a comment.
Optional: Social Subscribe/Login
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Leave a Reply
You must be logged in to post a comment.
Optional: Social Subscribe/Login